What is stereotactic ablative radiotherapy (SABR)?
Stereotactic ablative radiotherapy (SABR) is a specialised way of delivering radiotherapy which uses a small number of very precisely targeted treatments to destroy tumours whilst minimising damage to surrounding tissues.
SABR delivers very high doses of radiotherapy to a tumour and can offer some patients longer disease and symptom control and an improved quality of life. It can be used as an alternative to surgery, or where surgery isn’t an option, for example, if a tumour is located in an area which is difficult to operate on.
Stereotactic ablative radiotherapy uses rotational radiotherapy (VMAT) to focus a very high dose to the tumour and to lower or negate the dose to nearby healthy tissue or organs.
A full course of treatment is usually given in just three to eight sessions with each treatment is very precisely targeted using three-dimensional image guidance (IGRT).
Which conditions can be treated with SABR?
SABR is used to treat small primary cancers that have not spread, as well as metastases (a cancer that has spread). Currently, we use it to treat lung, spine, liver and bone tumours, as well as tumours in individual lymph nodes.
Patients treated with SABR
Please click here to find out more about Glynis Ebelthite experience of being treated with stereotactic ablative body radiotherapy (SABR).
Looking for more information?
For more information on SABR, please visit our SABR page on our HCP Hub.
CENTRAL region:Professor Maria Hawkins
Dr Veni Ezhil
Dr Qamar Ghafoor